Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2000
12/06/2000EP1057812A1 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
12/06/2000EP1057484A1 Cell death inhibitors
12/06/2000EP1056734A2 Substituted alxoxycarbonyl compounds
12/06/2000EP1056733A1 Histamine h3 receptor ligands
12/06/2000EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/06/2000EP1056726A1 Solid phase synthesis of 1-aminohydantoins
12/06/2000EP1056725A1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
12/06/2000EP1056724A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
12/06/2000EP1056719A2 Inhibitors of phospholipase enzymes
12/06/2000EP1056717A1 Arylphenyl-substituted cyclic keto-enols
12/06/2000CN1275979A Isoquinolines as urokinase inhibitors
12/06/2000CN1059213C Preparation of d4T from 5-methyluridine
12/06/2000CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine
12/05/2000US6156784 Ester, acid or derivatives of amides, sulfonamides or thioamides
12/05/2000US6156782 Parasiticidal compounds
12/05/2000US6156781 Antiinflammatory agents for skin
12/05/2000US6156779 Fungicides against candida
12/05/2000US6156761 Substituted tetralone derivatives for enhancing cognition
12/05/2000US6156737 Therapy for hepatitis b
12/05/2000US6156702 As herbicides
12/05/2000CA2008940C Method for the preparation of 4-(cyclic-amino)-2h-1-benzopyrans and 4-amino-3-hydroxy-2h-1-benzopyrans
11/2000
11/30/2000WO2000071572A1 Substituted beta-alanine derivatives as cell adhesion inhibitors
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071524A1 2-nh-pyridones and pyrimidones as mrs inhibitors
11/30/2000WO2000071522A1 Benzimidazole derivatives and their use as methionyl t-rna synthetase inhibitors
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000WO2000071517A1 Phenoxypropylamine compounds
11/30/2000WO2000071171A2 Sigma-1 ligands for determining carcinoma proliferative status
11/30/2000WO2000071120A1 Antibacterial compounds
11/30/2000WO2000047559A3 5-ht1f agonists
11/30/2000WO2000046199A3 Indole derivatives as anti-inflammation agents
11/30/2000WO2000044379A3 Methods for restoring and/or enhancing accommodation in pseudo phakia
11/30/2000CA2716369A1 Phenoxypropylamine compounds
11/30/2000CA2372887A1 Heterocyclic analgesic compounds and their use
11/29/2000EP1054960A1 Heteroaromatic oligoamides as affinity ligands
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054882A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
11/29/2000EP1054881A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054863A2 2-aminoquinoline derivatives having d4-agonistic activity
11/29/2000EP0702727B1 Dyes designed for high sensitivity detection of double-stranded dna
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/29/2000CN1274723A Dicyclic compound, medicine composition containing the same and use thereof
11/29/2000CN1274719A Process for preparation of substituted pyridine compound
11/29/2000CN1274718A Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same
11/29/2000CN1274528A N-(heterocycloformyl) sulfonamide herbicide
11/29/2000CN1058966C Producing process for crystal of z-oxyethyl -1-[2'-(1H-tetrazole-5-radical) diphenyl-4-(methyl) benzimidazole-7-hydroxy acid 1-(cyclohexyloxy)
11/29/2000CN1058961C Pyridine-2,3-dicarboxylic acid diamide derivatives and herbicides comprising said derivatives as active ingredient
11/28/2000US6153761 An intermediates for preparing herbicides and/or fungicides
11/28/2000US6153759 Herbicide comprising a 5-membered or 6-membered heterocyclic, saturated or unsaturated radical containing one to three hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen
11/28/2000US6153756 Salt formation by dissolving paclitaxel and a 2-halo-1-onium tosylate salt in a dry organic solvent, adding a quaternary compound forming agent to the mixture, purification by high performance liquid chromatography
11/28/2000US6153751 Preparing the antiviral b-isomer of a 1,3-oxathiolane nucleoside by reacting in presence of stannic chloride
11/28/2000US6153642 Useful as antineoplastic and antiviral agents
11/28/2000US6153640 For treating depression, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse or anxiety
11/28/2000US6153638 Administering efaroxan or its salt in racemic form or in the form of an optically-active isomer for treating huntington's disease
11/28/2000US6153627 For relaxing smooth muscle organs, blood circulation in coronary systems
11/28/2000US6153625 For treatment of disorders in which involvement of serotoninergic system has been demonstrated, as in psychiartic disorders such as depression, anxiety, panic attack, schizophrenia, aggression, impulsive disorders
11/28/2000US6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
11/28/2000US6153613 2,3-diketopiperazine derivatives or their salts
11/28/2000US6153589 2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents
11/28/2000CA2309475A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/23/2000WO2000069855A2 Furanone derivatives as inhibitors of cathepsin s
11/23/2000WO2000069852A1 Method for producing (r)-n-[(benzo[b]furan-2-yl)-alcoxycarbonyl]-tryptophane alkyl esters
11/23/2000WO2000069851A1 Method of producing (r)-n-[(benzo[b]furane-2-yl)-alkoxycarbonyl]-tryptophane alkyl esters
11/23/2000WO2000069850A1 Method for producing (r)-n-[(benzo[b]furan-2-yl)-alcoxycarbonyl]-tryptophane alkyl esters
11/23/2000WO2000069849A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders
11/23/2000WO2000069842A1 Benzofuranylsulfonates
11/23/2000WO2000069841A2 Benzofuranylaminoalcohols
11/23/2000WO2000069834A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069816A1 Metabotropic glutamate receptor antagonists
11/23/2000WO2000069815A1 Ureido-substituted cyclic amine derivatives and their use as drug
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000013681A3 4-quinolinemethanol derivatives as purine receptor antagonists (i)
11/23/2000DE19922462A1 New phenylureidobenzyl-substituted spiro-imidazolidinedione derivatives, are inhibitors of leukocyte adhesion or migration or VLA-4 receptors, useful e.g. for treating inflammatory or allergic disease
11/23/2000CA2374297A1 Furanone derivatives as inhibitors of cathepsin s
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/23/2000CA2373666A1 Benzofuranylsulfonates
11/23/2000CA2373607A1 Cyclic amine derivatives and their uses
11/23/2000CA2373510A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders
11/23/2000CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000CA2372617A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/23/2000CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/22/2000EP1054011A1 Novel antifungal compounds and process for producing the same
11/22/2000EP1054005A1 Sulfonamide derivatives, process for producing the same and utilization thereof
11/22/2000EP1054004A1 Novel pyrimidine-5-carboxamide derivatives
11/22/2000EP1054003A1 Urocanic acid derivatives
11/22/2000EP1053996A1 Ester compounds, liquid crystal compositions and liquid crystal display devices
11/22/2000EP1053234A1 Salts of paroxetine
11/22/2000EP1053233A1 Hydroxamic and carboxylic acid derivatives
11/22/2000EP1053230A1 Triazine antiviral compounds
11/22/2000EP1053227A1 Ppar-gamma modulators
11/22/2000EP1052992A1 Cyclic amine modulators of chemokine receptor activity
11/22/2000EP0736012B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 694